1. Home
  2. SRFM vs PLRX Comparison

SRFM vs PLRX Comparison

Compare SRFM & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surf Air Mobility Inc.

SRFM

Surf Air Mobility Inc.

HOLD

Current Price

$0.73

Market Cap

89.0M

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.15

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRFM
PLRX
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.0M
73.7M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
SRFM
PLRX
Price
$0.73
$1.15
Analyst Decision
Hold
Hold
Analyst Count
3
4
Target Price
$3.25
$2.67
AVG Volume (30 Days)
1.9M
362.2K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
45.69
29.97
EPS
N/A
N/A
Revenue
$106,557,000.00
N/A
Revenue This Year
$25.90
N/A
Revenue Next Year
$20.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$1.02
52 Week High
$6.17
$1.95

Technical Indicators

Market Signals
Indicator
SRFM
PLRX
Relative Strength Index (RSI) 44.58 56.96
Support Level $0.66 $1.12
Resistance Level $0.86 $1.26
Average True Range (ATR) 0.06 0.05
MACD 0.00 0.01
Stochastic Oscillator 27.81 64.29

Price Performance

Historical Comparison
SRFM
PLRX

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: